comparemela.com
Home
Live Updates
Idorsia Pharmaceuticals Ltd: QUVIVIQ (daridorexant) recommen
Idorsia Pharmaceuticals Ltd: QUVIVIQ (daridorexant) recommen
Idorsia Pharmaceuticals Ltd: QUVIVIQ (daridorexant) recommended for approval in Europe as a new treatment for adults with insomnia disorder
Ad hoc announcement pursuant to Art. 53 LR Idorsia receives a positive opinion from the Committee for Medicinal Products for Human Use for QUVIVIQ (daridorexant) for the treatment of adult patients
Related Keywords
Canada ,
Norway ,
Moscow ,
Moskva ,
Russia ,
Milan ,
Lombardia ,
Italy ,
United States ,
Allschwil ,
Switzerland General ,
Switzerland ,
United Kingdom ,
Texas ,
Colombo ,
Western ,
Sri Lanka ,
Liechtenstein ,
Northern Ireland ,
Craigavon ,
Baylor College Of Medicine ,
Germany ,
Iceland ,
Houston ,
Berlin ,
Italian ,
Great Britain ,
German ,
Swiss ,
American ,
Berliner Wirtschaftsgespr ,
Andrewc Weiss ,
Luigi Ferini Strambi ,
Cliffordb Saper ,
Ingo Fietze ,
Jean Paul Clozel ,
J Clin Pharmacol ,
American Psychiatric Association ,
World Association Of Sleep Medicine Society ,
European Sleep Research Society ,
World Sleep Federation ,
Disorders Center ,
Head Of The Interdisciplinary Center ,
Committee For Medicinal Products Human Use ,
Idorsia Ltd ,
Association For Pulmonologists ,
Italian Association Of Sleep Medicine ,
European Commission Decision Reliance Procedure ,
American Association Of Sleep Medicine ,
European Commission ,
Drug Administration ,
University Hospital Berlin ,
International Research Networks ,
Regulatory Agency ,
University Of Pittsburg ,
Journal Of Sleep Research ,
European Respiratory Society ,
Salute San Raffaele University ,
Head Of Investor Relations Corporate Communications ,
Department Of Neurology ,
German Sleep Society ,
Koch Metchnikoff Forum ,
European Union ,
German Sleep Foundation ,
European Union Member States ,
Study Group ,
German Respiratory Society ,
Swiss Exchange ,
Committee For Medicinal Products Human ,
European Medicines Agency ,
Idorsia Pharmaceuticals Ltd ,
Health Canada ,
German Society For Clinical Neurophysiology ,
German Cardiac Society ,
Medicinal Products ,
Human Use ,
Lancet Neurology ,
Paul Clozel ,
Chief Executive Officer ,
Vita Salute San Raffaele University ,
Insomnia Daytime Symptoms ,
Impacts Questionnaire ,
European Economic Area ,
Interdisciplinary Center ,
Sleep Medicine ,
German Society ,
Clinical Neurophysiology ,
American Association ,
Berlin Brandenburg ,
German Sleep ,
Professor Fietze ,
State University ,
Sleep Disorders Center ,
Baylor College ,
Postgraduate Degree ,
Scientific Instituteh San Raffaele Turro ,
Field Editor ,
Editorial Board ,
European Journal ,
Sleep Research ,
Italian Association ,
World Association ,
Statistical Manual ,
Mental Disorders ,
Discov Today Dis ,
Clin Sleep ,
Idorsia Pharmaceuticals ,
Vice President ,
Investor Relations ,
Pharmaceuticals Ltd ,
Idorsia ,
Pharmaceuticals ,
Quviviq ,
Daridorexant ,
Ecommended ,
Approval ,
Europe ,
Treatment ,
Adults ,
Insomnia ,
Disorder ,